In terms of fundamentals, Pfizer currently boasts a market capitalization of $132 billion. Over the last twelve months, the ...

The earnings season enters its second busiest week. After the shockingly weak jobs report, concerns about the economy creep ...

Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.

Greek-American Pfizer CEO Albert Bourla attended a $25 million MAGA Inc. fundraiser at Trump’s Bedminster golf club, ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million-pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals ...

Pfizer-BioNTech's COVID-19 vaccine has a new name: Comirnaty. If your brain starts to melt a little when you try to figure out how it's pronounced, don't worry.